Addii Biotech at CPHI and PMEC India 2025

Addii Biotech participated in CPHI & PMEC India 2025, held from 25th to 27th November 2025 at India Expo Centre, Greater Noida, Delhi NCR. The event provided an important platform for pharmaceutical manufacturers, industry professionals, innovators, and global healthcare businesses to connect, exchange ideas, and explore new opportunities. Addii Biotech showcased its pharmaceutical manufacturing capabilities, including third-party pharma manufacturing, PCD pharma franchise solutions, high-quality formulations, and innovative pharmaceutical products. With a focus on quality, regulatory compliance, and continuous innovation, the company highlighted its WHO-GMP and ISO-certified manufacturing excellence. Visitors to Booth RH E58 had the opportunity to explore Addii Biotech’s expanding portfolio of tablets, capsules, syrups, ointments, and other pharmaceutical formulations, along with its modern manufacturing infrastructure and quality-driven production processes. The participation also enabled Addii Biotech to connect with global pharma professionals, potential partners, distributors, and industry leaders to discuss collaboration opportunities and future healthcare solutions. CPHI & PMEC India 2025 served as a valuable platform for Addii Biotech to strengthen industry relationships, showcase its capabilities, and expand its global pharmaceutical network. Through participation in major pharmaceutical exhibitions, Addii Biotech continues to demonstrate its commitment to delivering high-quality, affordable, and innovative healthcare solutions to customers and business partners across India and international markets. The company remains focused on building meaningful collaborations and contributing to the growth and development of the global pharmaceutical industry through quality manufacturing, ethical business practices, and customer-focused pharmaceutical solutions.